TP-271 Uses, Dosage, Side Effects and more
TP-271 is under investigation in clinical trial NCT02724085 (A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271).
| Trade Name | TP-271 |
| Generic | TP-271 |
| Type | |
| Formula | C27H31FN4O8 |
| Weight | Average: 558.563 Monoisotopic: 558.212592137 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
